Phase I Study of 4'-Thio-araC in Patients With Advanced Hematologic Malignancies.
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2014
At a glance
- Drugs Thiarabine (Primary)
- Indications Acute nonlymphocytic leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Chronic myelomonocytic leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 23 Nov 2013 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center.
- 14 Jun 2012 New source identified and integrated (M.D. Anderson Cancer Center: 2009-1000).
- 14 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.